vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $30.9M, roughly 1.5× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs -4.8%, a 51.4% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (5.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $35.9M). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (2.7% CAGR vs -20.2%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

CHCT vs IRWD — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.5× larger
IRWD
$47.7M
$30.9M
CHCT
Growing faster (revenue YoY)
CHCT
CHCT
+52.9% gap
CHCT
5.6%
-47.3%
IRWD
Higher net margin
CHCT
CHCT
51.4% more per $
CHCT
46.6%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$38.7M more FCF
IRWD
$74.6M
$35.9M
CHCT
Faster 2-yr revenue CAGR
CHCT
CHCT
Annualised
CHCT
2.7%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHCT
CHCT
IRWD
IRWD
Revenue
$30.9M
$47.7M
Net Profit
$14.4M
$-2.3M
Gross Margin
Operating Margin
14.3%
Net Margin
46.6%
-4.8%
Revenue YoY
5.6%
-47.3%
Net Profit YoY
687.6%
-200.9%
EPS (diluted)
$0.52
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
IRWD
IRWD
Q4 25
$30.9M
$47.7M
Q3 25
$31.1M
$122.1M
Q2 25
$29.1M
$85.2M
Q1 25
$30.1M
$41.1M
Q4 24
$29.3M
$90.5M
Q3 24
$29.6M
$91.6M
Q2 24
$27.5M
$94.4M
Q1 24
$29.3M
$74.9M
Net Profit
CHCT
CHCT
IRWD
IRWD
Q4 25
$14.4M
$-2.3M
Q3 25
$1.6M
$40.1M
Q2 25
$-12.6M
$23.6M
Q1 25
$1.6M
$-37.4M
Q4 24
$1.8M
$2.3M
Q3 24
$1.7M
$3.6M
Q2 24
$-10.4M
$-860.0K
Q1 24
$3.7M
$-4.2M
Operating Margin
CHCT
CHCT
IRWD
IRWD
Q4 25
14.3%
Q3 25
61.8%
Q2 25
53.2%
Q1 25
-70.7%
Q4 24
34.8%
Q3 24
28.0%
Q2 24
26.5%
Q1 24
14.7%
Net Margin
CHCT
CHCT
IRWD
IRWD
Q4 25
46.6%
-4.8%
Q3 25
5.3%
32.8%
Q2 25
-43.2%
27.7%
Q1 25
5.3%
-90.9%
Q4 24
6.3%
2.5%
Q3 24
5.9%
4.0%
Q2 24
-37.9%
-0.9%
Q1 24
12.5%
-5.6%
EPS (diluted)
CHCT
CHCT
IRWD
IRWD
Q4 25
$0.52
$0.01
Q3 25
$0.03
$0.23
Q2 25
$-0.50
$0.14
Q1 25
$0.03
$-0.23
Q4 24
$0.04
$0.03
Q3 24
$0.04
$0.02
Q2 24
$-0.42
$-0.01
Q1 24
$0.11
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$3.3M
$215.5M
Total DebtLower is stronger
$532.2M
Stockholders' EquityBook value
$429.4M
$-261.8M
Total Assets
$990.8M
$396.9M
Debt / EquityLower = less leverage
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
IRWD
IRWD
Q4 25
$3.3M
$215.5M
Q3 25
$3.4M
$140.4M
Q2 25
$4.9M
$92.9M
Q1 25
$2.3M
$108.5M
Q4 24
$4.4M
$88.6M
Q3 24
$2.8M
$88.2M
Q2 24
$734.0K
$105.5M
Q1 24
$3.8M
$121.5M
Total Debt
CHCT
CHCT
IRWD
IRWD
Q4 25
$532.2M
Q3 25
$530.1M
$199.5M
Q2 25
$500.1M
$199.3M
Q1 25
$496.0M
$199.2M
Q4 24
$486.0M
$199.0M
Q3 24
$473.7M
$198.8M
Q2 24
$457.6M
$198.6M
Q1 24
$442.3M
$398.3M
Stockholders' Equity
CHCT
CHCT
IRWD
IRWD
Q4 25
$429.4M
$-261.8M
Q3 25
$426.8M
$-264.2M
Q2 25
$437.8M
$-308.2M
Q1 25
$461.3M
$-334.1M
Q4 24
$476.0M
$-301.3M
Q3 24
$477.2M
$-311.3M
Q2 24
$497.8M
$-321.7M
Q1 24
$511.6M
$-330.5M
Total Assets
CHCT
CHCT
IRWD
IRWD
Q4 25
$990.8M
$396.9M
Q3 25
$987.3M
$396.1M
Q2 25
$966.3M
$342.9M
Q1 25
$985.1M
$327.2M
Q4 24
$992.6M
$350.9M
Q3 24
$981.8M
$389.5M
Q2 24
$983.2M
$395.6M
Q1 24
$982.7M
$438.8M
Debt / Equity
CHCT
CHCT
IRWD
IRWD
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×
Q1 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
IRWD
IRWD
Operating Cash FlowLast quarter
$56.4M
$74.6M
Free Cash FlowOCF − Capex
$35.9M
$74.6M
FCF MarginFCF / Revenue
116.0%
156.3%
Capex IntensityCapex / Revenue
66.3%
0.0%
Cash ConversionOCF / Net Profit
3.91×
TTM Free Cash FlowTrailing 4 quarters
$62.8M
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
IRWD
IRWD
Q4 25
$56.4M
$74.6M
Q3 25
$12.7M
$47.6M
Q2 25
$13.8M
$-15.1M
Q1 25
$14.4M
$20.0M
Q4 24
$58.9M
$15.2M
Q3 24
$13.8M
$9.9M
Q2 24
$16.7M
$33.5M
Q1 24
$12.6M
$45.0M
Free Cash Flow
CHCT
CHCT
IRWD
IRWD
Q4 25
$35.9M
$74.6M
Q3 25
$7.6M
$47.6M
Q2 25
$9.6M
$-15.1M
Q1 25
$9.7M
$19.9M
Q4 24
$34.2M
Q3 24
$6.7M
$9.9M
Q2 24
$9.5M
$33.4M
Q1 24
$7.5M
$44.9M
FCF Margin
CHCT
CHCT
IRWD
IRWD
Q4 25
116.0%
156.3%
Q3 25
24.6%
39.0%
Q2 25
32.9%
-17.7%
Q1 25
32.3%
48.4%
Q4 24
116.9%
Q3 24
22.5%
10.8%
Q2 24
34.7%
35.4%
Q1 24
25.7%
60.0%
Capex Intensity
CHCT
CHCT
IRWD
IRWD
Q4 25
66.3%
0.0%
Q3 25
16.3%
0.0%
Q2 25
14.5%
0.0%
Q1 25
15.6%
0.1%
Q4 24
84.1%
0.0%
Q3 24
24.2%
0.0%
Q2 24
26.1%
0.1%
Q1 24
17.4%
0.1%
Cash Conversion
CHCT
CHCT
IRWD
IRWD
Q4 25
3.91×
Q3 25
7.76×
1.19×
Q2 25
-0.64×
Q1 25
9.06×
Q4 24
32.14×
6.74×
Q3 24
7.92×
2.71×
Q2 24
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons